Avidity Biosciences Stock (NASDAQ: RNA) stock price, news, charts, stock research, profile.
Open | $40.56 |
Close | $40.85 |
Volume / Avg. | 7.73M / 1.36M |
Day Range | 40.01 - 41.50 |
52 Wk Range | 4.83 - 42.00 |
Market Cap | $4.41B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 74 |
Short Interest | 13.22% |
Days to Cover | 4.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Avidity Biosciences (NASDAQ:RNA) through any online brokerage.
Other companies in Avidity Biosciences’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Alkermes (NASDAQ:ALKS), SpringWorks Therapeutics (NASDAQ:SWTX) and Viking Therapeutics (NASDAQ:VKTX).
There is no analysis for Avidity Biosciences.
Avidity Biosciences has a consensus price target of $46.20.
The stock price for Avidity Biosciences (NASDAQ: RNA) is $40.88 last updated June 28, 2024 at 5:10 PM EDT.
There are no upcoming dividends for Avidity Biosciences.
Avidity Biosciences’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Avidity Biosciences.
Avidity Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.